Latest Regulatory News

EQ Resources Limited has successfully raised $18.8 million through a share placement, complemented by a $3 million Share Purchase Plan, to fund its tungsten mining projects and reduce debt.

The Takeovers Panel has declined to investigate applications challenging Pact Group Holdings’ proposed delisting, signaling regulatory acceptance of the move. The decision clarifies the Panel’s jurisdiction and leaves the delisting process on track.

Euro Manganese is poised to close a C$11.2 million financing round by late May, fueling progress on its strategic Chvaletice manganese project in the Czech Republic. The move underscores the company's role in Europe's battery materials supply chain.

Hutchison Telecommunications (Amsterdam) B.V., a subsidiary of CK Hutchison Holdings, has made a takeover offer for all shares in Hutchison Telecommunications (Australia) Limited at A$0.032 per share, representing a significant premium to recent trading prices. The offer requires at least 97% acceptance to proceed and aims to delist HTAL from the ASX.

The ACCC has decided not to oppose Insurance Australia Group’s proposed acquisition of RACQ Insurance, finding that competition in Queensland’s motor and home contents insurance markets remains robust despite the deal.

HyTerra Limited has reported exceptional hydrogen and helium concentrations from its Sue Duroche 3 well in Kansas, marking a significant milestone in natural gas exploration and clean energy potential.

Mayne Pharma has clarified why it did not disclose an FDA Untitled Letter to the market despite sharing it with its scheme bidder, reaffirming compliance with ASX rules amid recent share price volatility.

OD6 Metals has secured regulatory approval to launch an 18-hole, 5,000-metre drilling program at its Gulf Creek Copper Project, targeting promising repeat mineral structures. A further 7-hole deep drilling phase awaits approval, potentially expanding exploration near historic high-grade copper zones.

Ventia Services Group Limited delivered strong financial results for 2024, highlighted by a 12.8% rise in NPATA and a record 92% contract renewal rate, while reaffirming growth guidance despite ongoing ACCC proceedings.

Dimerix Limited’s ACTION3 Phase 3 trial for DMX-200 in treating FSGS kidney disease has passed its sixth independent safety review with no concerns, reinforcing the drug’s promising safety profile.

Rapid Lithium Limited has agreed to acquire two high-grade silver projects in New South Wales, adding nearly 35 million silver equivalent ounces to its portfolio. The deal, valued at A$6.5 million, signals a strategic diversification into critical minerals amid a robust silver market.

Hutchison Telecommunications (Amsterdam) B.V. has announced an off-market takeover bid for the 12.13% of Hutchison Telecommunications (Australia) Limited shares it does not already own, offering a 52.4% premium. The move aims to consolidate full ownership of the Australian telecom operator.